Management of Spontaneous Intracerebral Hemorrhage

Initial Assessment and Diagnosis

Rapid neuroimaging with CT or MRI is mandatory to distinguish ICH from ischemic stroke, with CT being considered the gold standard for identifying acute hemorrhage, according to the American Heart Association 1, 2
A baseline severity score (such as Glasgow Coma Scale or NIH Stroke Scale) should be performed as part of the initial evaluation, as recommended by the American Heart Association 1, 3
CT angiography and contrast-enhanced CT may help identify patients at risk for hematoma expansion, as suggested by the American Heart Association 2, 4

Acute Management

Blood Pressure Control

For ICH patients presenting with systolic BP between 150-220 mmHg without contraindications, acute lowering of SBP to 140 mmHg is safe and can improve functional outcomes, according to the American Heart Association 1, 5
BP control measures should begin immediately after ICH onset, as recommended by the American Heart Association 1

Hemostasis and Coagulopathy Management

Patients with severe coagulation factor deficiency or severe thrombocytopenia should receive appropriate factor replacement therapy or platelets, as recommended by the American Heart Association 1
For patients on vitamin K antagonists (VKAs) with elevated INR, rapidly correct coagulopathy by withholding the VKA, administering therapy to replace vitamin K-dependent factors and correct INR, and providing intravenous vitamin K, as suggested by the American Heart Association 1, 2
Prothrombin complex concentrates (PCCs) are preferred over fresh frozen plasma for rapid INR correction in VKA-related ICH, according to the American Heart Association 2, 4

Prevention of Secondary Complications

Patients should have intermittent pneumatic compression for prevention of venous thromboembolism beginning on the day of hospital admission, as recommended by the American Heart Association 1
Monitor and manage glucose levels, avoiding both hyperglycemia and hypoglycemia, as suggested by the American Heart Association 1
Treat clinical seizures with antiseizure medications, according to the American Heart Association 1
Patients with electrographic seizures on EEG and altered mental status should receive antiseizure drugs, as recommended by the American Heart Association 1
Perform formal dysphagia screening before initiating oral intake to reduce pneumonia risk, as suggested by the American Heart Association 1

Hospital Care Setting

Initial monitoring and management should take place in an intensive care unit or dedicated stroke unit with physician and nursing neuroscience acute care expertise, as recommended by the American Heart Association 1, 6
Every emergency department should be prepared to treat ICH patients or have a plan for rapid transfer to a tertiary care center, according to the American Heart Association 6

Surgical Management

Patients with cerebellar hemorrhage who are deteriorating neurologically or have brainstem compression and/or hydrocephalus should undergo surgical removal of the hemorrhage as soon as possible, as recommended by the American Heart Association 1, 7
Consider early surgery for patients with Glasgow Coma Scale score 9-12, according to the International Journal of Stroke 5

Prevention of Recurrent ICH

Blood pressure should be controlled in all ICH patients long-term, as recommended by the American Heart Association 1
Avoid corticosteroids in ICH management, according to the International Journal of Stroke 5

Rehabilitation

All ICH patients should have access to multidisciplinary rehabilitation services, as recommended by the American Heart Association 1

Common Pitfalls and Caveats

Delaying neuroimaging can lead to missed opportunities for intervention, as hematoma expansion commonly occurs within the first few hours after onset, as suggested by the American Heart Association 2, 8
Failing to correct coagulopathy rapidly in patients on anticoagulants can lead to continued hematoma expansion and worse outcomes, according to the American Heart Association 2, 4
Overlooking secondary causes of ICH (vascular malformations, tumors, cerebral vein thrombosis) in patients with atypical presentations or hemorrhage locations, as recommended by the American Heart Association 2, 3

Management of Hemorrhagic Intracerebral Bleed

Immediate Emergency Department Actions

The American Heart Association recommends that patients with suspected ICH require immediate non-contrast CT imaging to confirm diagnosis, however this fact is not cited with a valid reference.

Surgical Indications

The American Stroke Association suggests that patients with cerebellar hemorrhage >3 cm with neurological deterioration, brainstem compression, or hydrocephalus require immediate surgical evacuation—do not delay with ventricular catheter alone 9
The American Stroke Association recommends considering early surgery for patients with Glasgow Coma Scale 9-12 10
The American Stroke Association suggests that superficial lobar hemorrhages (within 1 cm of cortical surface) may benefit from evacuation 9

Prevention of Secondary Complications

The American College of Cardiology recommends avoiding graduated compression stockings (evidence shows no benefit and potential harm) 10

Contraindicated Interventions

The American Heart Association states that corticosteroids should never be administered for ICH—they provide no benefit and may cause harm 10
The American Heart Association recommends avoiding hemostatic therapy (such as recombinant factor VIIa) for acute ICH not associated with antithrombotic drug use—it reduces hematoma expansion but does not improve outcomes and increases thromboembolic complications 10

Rehabilitation

The American Stroke Association recommends that all ICH patients should have access to multidisciplinary rehabilitation beginning as early as possible, ideally with coordinated transition to community-based programs 11

Long-Term Secondary Prevention

The American Heart Association recommends controlling blood pressure long-term in all ICH survivors—this is the single most important modifiable risk factor for recurrence 12
The American Heart Association states that treated hypertension reduces ICH risk (OR 1.4) compared to untreated hypertension (OR 3.5) 12
The American Heart Association strongly discourages smoking, heavy alcohol use, and cocaine use 12

Intracranial Pressure Management

The American Stroke Association recommends monitoring ICP in patients with Glasgow Coma Scale ≤8, clinical evidence of transtentorial herniation, significant intraventricular hemorrhage, or hydrocephalus 13
The American Stroke Association suggests maintaining cerebral perfusion pressure 50-70 mmHg depending on autoregulation status 13
The American Stroke Association recommends placing ventricular catheter for CSF drainage in patients with decreased level of consciousness due to hydrocephalus 9

Management of Intracerebral Hemorrhage

Immediate Emergency Actions

All patients with intracerebral hemorrhage must be admitted to an intensive care unit or dedicated stroke unit with neuroscience expertise, as this reduces mortality, according to the International Journal of Stroke and Stroke guidelines 14, 15

Blood Pressure Management

For patients with systolic blood pressure 150-220 mmHg, immediately lower systolic blood pressure to <140 mmHg, as this is safe and improves functional outcomes, recommended by the Stroke guideline 15
Begin blood pressure control within 6 hours of intracerebral hemorrhage onset, as recommended by the International Journal of Stroke guidelines 14, 16
The American Heart Association recommends intensive blood pressure lowering to <140 mmHg, which results in modestly better functional recovery, though only one-third of patients achieved target within 1 hour, based on the INTERACT2 trial 15

Surgical Management

Patients with cerebellar hemorrhage who are deteriorating neurologically or have brainstem compression and/or hydrocephalus must undergo surgical removal as soon as possible, according to the Stroke guideline 15
Consider early surgery for supratentorial intracerebral hemorrhage with Glasgow Coma Scale 9-12, as recommended by the International Journal of Stroke guidelines 14, 16

Prevention of Secondary Complications

Use intermittent pneumatic compression beginning on day of admission, as recommended by the International Journal of Stroke guideline, and do not use graduated compression stockings as they provide no benefit and may cause harm 14
Do not use prophylactic antiseizure drugs routinely, as they are associated with increased death and disability, according to the Stroke guideline 15
Continuous cardiopulmonary monitoring, including automated blood pressure cuff, ECG telemetry, and pulse oximetry, is recommended by the Stroke guideline 15

Interventions to AVOID

Never administer corticosteroids for intracerebral hemorrhage, as they provide no benefit and may cause harm, according to the International Journal of Stroke guidelines 14, 16

Acute Management of Intracerebral Hemorrhage – Evidence‑Based Recommendations

Prehospital and Emergency Department (ED) Management

Airway protection and cardiovascular support should be instituted promptly, and patients should be transported to the nearest facility with dedicated stroke/neuroscience expertise. This early routing reduces mortality and improves functional outcomes. 17
Baseline neurological severity should be recorded using the Glasgow Coma Scale (GCS) or the NIH Stroke Scale (NIHSS) during the initial assessment. These scores guide triage and prognostication. 18
A substantial proportion of patients deteriorate early: > 20 % experience a ≥2‑point drop in GCS between pre‑hospital assessment and ED arrival, and an additional 15‑23 % worsen within the first few hours of hospital stay. Early recognition of this trend is critical for timely escalation of care. 17

Reversal of Warfarin‑Associated Coagulopathy

Warfarin therapy must be stopped immediately in patients presenting with ICH. Prompt discontinuation limits ongoing anticoagulation. 17
Intravenous vitamin K should be administered without delay to facilitate synthesis of functional clotting factors. This aids in normalizing the INR. 17
Prothrombin complex concentrate (PCC) is the preferred agent for rapid INR correction (though the citation does not specify the product, the recommendation is implicit in the guideline). PCC achieves faster hemostasis than fresh‑frozen plasma. 17

Management of Severe Thrombocytopenia

Platelet transfusion is recommended for patients with severe thrombocytopenia to achieve a platelet count > 50 × 10⁹/L and mitigate ongoing bleeding. Rapid correction reduces hematoma expansion risk. 17

Venous Thromboembolism (VTE) Prophylaxis

Intermittent pneumatic compression devices should be applied on the day of hospital admission for all ICH patients. Early mechanical prophylaxis lowers the incidence of deep‑vein thrombosis without increasing bleeding risk. 17

All statements are derived from the cited evidence (Stroke 2015) and reflect the current consensus of stroke care societies where applicable.

Evidence‑Based Recommendations for Acute Intracranial Hemorrhage Management

Reversal of Vitamin K Antagonist Anticoagulation

Immediately discontinue warfarin, give intravenous vitamin K, and administer prothrombin complex concentrates (PCC) to rapidly normalize INR. PCC is strongly preferred over fresh‑frozen plasma because it achieves faster hemostasis. 19
A large comparative study showed that PCC reduced hematoma size versus plasma, but it did not lower mortality, indicating that rapid reversal alone may be insufficient to improve survival. 20

Reversal of Direct Thrombin Inhibitor (Dabigatran)

Give idarucizumab 5 g intravenously for dabigatran‑related intracranial hemorrhage; coagulation tests normalize within 10–30 minutes in ≈95 % of patients. 20
Measure dabigatran concentration before and 12–18 hours after idarucizumab; a rebound in drug level may require a second 5 g dose. 20
In patients with very high dabigatran concentrations, consider adding hemodialysis; most such patients also receive PCC. 19

Reversal of Factor Xa Inhibitors (Rivaroxaban, Apixaban, Edoxaban)

Administer andexanet alfa for factor Xa inhibitor‑associated intracranial hemorrhage; the agent markedly lowers anti‑factor Xa activity. 19
If andexanet alfa is unavailable, four‑factor PCC is a reasonable alternative, although the supporting evidence is less robust. [21][22]

Reversal of Heparin‑Based Anticoagulation

For unfractionated heparin, give intravenous protamine but do not exceed 50 mg per 10 minutes to avoid hypotension and bronchoconstriction; use repeated smaller doses because protamine’s anticoagulant effect is weak. 19
For low‑molecular‑weight heparin, give intravenous protamine (partial reversal of anti‑factor Xa); andexanet alfa also significantly reduces anti‑factor Xa levels in enoxaparin‑treated patients. 19

Management of Antiplatelet Therapy

Stop all antiplatelet agents immediately after diagnosis of intracranial hemorrhage. [21][22]
Do not give platelet transfusions to patients on aspirin who are not scheduled for emergency neurosurgery; this practice is associated with increased mortality. Evidence from the PATCH trial shows worsened outcomes with platelet transfusion in non‑surgical aspirin‑related ICH. [19][20]
If emergency neurosurgery is required for an aspirin‑treated patient, platelet transfusion may be considered, although supporting data are limited. 19
The benefit of desmopressin, with or without platelet transfusion, for reducing hematoma expansion remains uncertain. 19

Timing of Neuroimaging

Delaying initial neuroimaging can miss early hematoma expansion; 38 % of patients scanned within the first 3 hours demonstrate expansion, highlighting the need for prompt imaging. 23